Synthesis and biological activity of new 6-benzylisocytosine derivatives: non-nucleoside HIV-1 reverse transcriptase inhibitors

被引：5
作者：
Valuev-Elliston, V. T. [1 ]
Ivanov, A. V. [1 ]
Orlinson, B. S. [2 ]
Gerasimov, E. N. [2 ]
Brunilina, L. L. [2 ]
Kochetkov, S. N. [1 ]
Novakov, I. A. [2 ]
Navrotskii, M. B. [2 ]
机构：
[1] Russian Acad Sci, VA Engelhardt Mol Biol Inst, Moscow, Russia
[2] Volgograd State Tech Univ, Volgograd, Russia
来源：
PHARMACEUTICAL CHEMISTRY JOURNAL | 2012年 / 46卷 / 07期
关键词：
6-benzylisocytosine derivatives; HIV-1 reverse transcriptase inhibitors; ANTI-HIV-1; ACTIVITY; POTENT; AGENTS; FAMILY;
D O I：
10.1007/s11094-012-0808-y
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
New 6-benzylisocytosine derivatives were synthesized by aminolysis of 6-benzyl-2-(methylsulfanyl)pyrimidin-4(3H)-ones with aliphatic aromatic and cage-structured amines. Some of the synthesized compounds appeared to be effective HIV-1 reverse transcriptase inhibitors. Among these, 6-(2,6-difluorobenzyl)-5-methyl-2-[(2-phenylethyl)amino]pyrimidin-4(3H)-one showed the most pronounced inhibitory properties, being nine times more effective than the reference anti-HIV drug nevirapine.
引用
收藏
页码：397 / 401
页数：5
相关论文
共 50 条
  • [31] Synthesis and biological evaluation of dihydroquinazoline-2-amines as potent non-nucleoside reverse transcriptase inhibitors of wild-type and mutant HIV-1 strains
    Jin, KaiJun
    Sang, YaLi
    Han, Sheng
    De Clercq, Erik
    Pannecouque, Christophe
    Meng, Ge
    Chen, FenEr
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 176 : 11 - 20
  • [32] ANN QSAR workflow for predicting the inhibition of HIV-1 reverse transcriptase by pyridinone non-nucleoside derivatives
    Barzegar, Abolfazl
    Zamani-Gharehchamani, Elham
    Kadkhodaie-Ilkhchi, Ali
    FUTURE MEDICINAL CHEMISTRY, 2017, 9 (11) : 1175 - 1191
  • [33] Indolylarylsulfones as HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: New Cyclic Substituents at Indole-2-carboxamide
    La Regina, Giuseppe
    Coluccia, Antonio
    Brancale, Andrea
    Piscitelli, Francesco
    Gatti, Valerio
    Maga, Giovanni
    Samuele, Alberta
    Pannecouque, Christophe
    Schols, Dominique
    Balzarini, Jan
    Novellino, Ettore
    Silvestri, Romano
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (06) : 1587 - 1598
  • [34] Design, discovery, modelling, synthesis, and biological evaluation of novel and small, low toxicity s-triazine derivatives as HIV-1 non-nucleoside reverse transcriptase inhibitors
    Viira, Birgit
    Selyutina, Anastasia
    Garcia-Sosa, Alfonso T.
    Karonen, Maarit
    Sinkkonen, Jari
    Merits, Andres
    Maran, Uko
    BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (11) : 2519 - 2529
  • [35] Advances in the development of pyridinone derivatives as non-nucleoside reverse transcriptase inhibitors
    Vite-Caritino, Hugo
    Mendez-Lucio, Oscar
    Reyes, Hector
    Cabrera, Alberto
    Chavez, Daniel
    Medina-Franco, Jose L.
    RSC ADVANCES, 2016, 6 (03): : 2119 - 2130
  • [36] Tri-substituted 1,3,5-triazine-based analogs as effective HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs): A systematic review
    Khalifa, Zebabanu
    Patel, Amit B.
    DRUG DEVELOPMENT RESEARCH, 2024, 85 (01)
  • [37] Substituted indoles as HIV-1 non-nucleoside reverse transcriptase inhibitors: a patent evaluation (WO2015044928)
    Li, Xiao
    Gao, Ping
    Zhan, Peng
    Liu, Xinyong
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2016, 26 (05) : 629 - 635
  • [38] Synthesis and biological evaluation of novel C5 halogen-functionalized S-DABO as potent HIV-1 non-nucleoside reverse transcriptase inhibitors
    Qin, Hua
    Liu, Chang
    Guo, Ying
    Wang, Ruiping
    Zhang, Jianfang
    Ma, Liying
    Zhang, Zhili
    Wang, Xiaowei
    Cui, Yuxin
    Liu, Junyi
    BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (09) : 3231 - 3237
  • [39] Conformational restriction design of thiophene-biphenyl-DAPY HIV-1 non-nucleoside reverse transcriptase inhibitors
    Sang, Yali
    Han, Sheng
    Pannecouque, Christophe
    De Clercq, Erik
    Zhuang, Chunlin
    Chen, Fener
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 182
  • [40] Design of novel leads: ligand based computational modeling studies on non-nucleoside reverse transcriptase inhibitors (NNRTIs) of HIV-1
    Jain , Nilanjana
    Gupta, Swagata
    Sapre, Neelima
    Sapre, Nitin S.
    MOLECULAR BIOSYSTEMS, 2014, 10 (02) : 313 - 325
12345